Neurodegenerative Disorder Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Diagnostics News

Optive AI Gets FDA Clearance, Elevates Image Quality for Swoop Portable MRI

BrainSense Brain Stimulation System from Medtronic Wins FDA Nod for Parkinson’s

February 28, 2025

FDA Greenlights Monthly IV Dosing for Alzheimer’s Med Leqembi

January 29, 2025

BlueRock Advances Bemdaneprocel Cell Therapy to Phase III Trial for Parkinson’s Disease

January 16, 2025

Clinical Trial News

AbbVie’s Tavapadon Reduces Motor Impairments in Phase III Parkinson’s Trial

December 11, 2024

Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO

December 4, 2024

How GE HealthCare’s SIGNA MAGNUS 3.0T Transforms Neuroimaging

November 13, 2024

Clinical Trial News

Troriluzole: New Data Shows Delayed Disease Worsening in Spinocerebellar Ataxia Patients

October 3, 2024

Clinical Trial News

Tavapadon Shows Promise in Enhancing Daily Function for Early Parkinson’s Patients

September 30, 2024

Working Faster Than the Speed of ALS to Transform Neurodegenerative Disease Research

September 30, 2024

World Alzheimer’s Day 2024: Innovative Therapies and More

September 18, 2024

Ocrevus Zunovo Subcutaneous Solution for MS Gains FDA Approval

September 16, 2024

Life Science News

Amylyx Receives Orphan Drug Designation in Europe for Former ALS Drug in Wolfram Syndrome

Zunveyl Approved as New Oral Med for Alzheimer’s Disease

Life Science News

New Link Found Between Parkinson’s Disease and Microbiome

December 5, 2016

AAIC 2016: Highlights In Prevention, Detection And Treatment Of Alzheimer’s Disease